Evidence map›Paper›PMID 34842295›Full record

ArticleThe EMBO journal2022

Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure.

Katerina Konstantoulea, Patricia Guerreiro, Meine Ramakers, Nikolaos Louros, Liam D Aubrey, Bert Houben, Emiel Michiels, Matthias De Vleeschouwer, Yulia Lampi, Luís F Ribeiro and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Medin drives Aβ40 to adopt Aβ42-like fibril polymorphs in vitro.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Heterotypic Seeding Generates Mixed Amyloid Polymorphs.bioRxiv : the preprint server for biology · 2024
    Article
  16. Mechanisms and pathology of protein misfolding and aggregation.Nature reviews. Molecular cell biology · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Katerina KonstantouleaSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.ORCID 0000-0002-0960-6274
Patricia GuerreiroSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
Meine RamakersSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.ORCID 0000-0002-9417-4196
Nikolaos LourosSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
Liam D AubreySchool of Biosciences, University of Kent, Canterbury, UK.
Bert HoubenSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.ORCID 0000-0002-6750-011X
Emiel MichielsSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
Matthias De VleeschouwerSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
Yulia LampiSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
Luís F RibeiroVIB Center for Brain & Disease Research, Leuven, Belgium.
Joris de WitVIB Center for Brain & Disease Research, Leuven, Belgium.
Wei-Feng XueSchool of Biosciences, University of Kent, Canterbury, UK.ORCID 0000-0002-6504-0404
Joost SchymkowitzSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.ORCID 0000-0003-2020-0168
Frederic RousseauSwitch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.ORCID 0000-0002-9189-7399
VIB-KU Leuven Center for Brain & Disease Research · BEUniversity of Kent · GB

Funding

Heterotypic amyloid interactions as modulators of selective cellular vulnerabilityR01AG079234 · NIA · FLANDERS INTERUNIV INST BIOTECHNOLOGY · PI Frederic Rousseau, Joost Schymkowitz · 2022 to 2026
$2.5M
Biotechnology and Biological Sciences Research Council BB/S003312/1
6 · The paper itself

Abstract

It is still unclear why pathological amyloid deposition initiates in specific brain regions or why some cells or tissues are more susceptible than others. Amyloid deposition is determined by the self-assembly of short protein segments called aggregation-prone regions (APRs) that favour cross-β structure. Here, we investigated whether Aβ amyloid assembly can be modified by heterotypic interactions between Aβ APRs and short homologous segments in otherwise unrelated human proteins. Mining existing proteomics data of Aβ plaques from AD patients revealed an enrichment in proteins that harbour such homologous sequences to the Aβ APRs, suggesting heterotypic amyloid interactions may occur in patients. We identified homologous APRs from such proteins and show that they can modify Aβ assembly kinetics, fibril morphology and deposition pattern in vitro. Moreover, we found three of these proteins upon transient expression in an Aβ reporter cell line promote Aβ amyloid aggregation. Strikingly, we did not find a bias towards heterotypic interactions in plaques from AD mouse models where Aβ self-aggregation is observed. Based on these data, we propose that heterotypic APR interactions may play a hitherto unrealized role in amyloid-deposition diseases.

Indexed as

Protein Interaction MapsAmyloid beta-PeptidesHEK293 CellsHumansProtein BindingProtein MultimerizationProteomeAmyloid beta-PeptidesProteomeAlzheimer’s diseaseamyloid betaheterotypic aggregationtoxicity

Identifiers

PMID34842295
PMCPMC8762568
OpenAlexW3214964819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.